Related Experiment Video
Updated: Jun 21, 2026

A Human 3D Extracellular Matrix-Adipocyte Culture Model for Studying Matrix-Cell Metabolic Crosstalk
Published on: November 7, 2019
Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation
Anders Gummesson1, Daniel Hagg, Fredrik J Olson
1Department of Molecular and Clinical Medicine, Center for Cardiovascular and Metabolic Research, The Sahlgrenska Academy at Gothenburg University, University of Gothenburg, Gothenburg, Sweden. anders.gummesson@gu.se
Objectives:
Matrix metalloproteinase 9 (MMP-9) is overexpressed in atherosclerotic plaques and in many cancers, and has emerged as a potential circulating biomarker for such diseases. However, adipose tissue (AT) might also produce circulating MMP-9, thereby reducing the value of MMP-9 as a biomarker. The aim of this study was to evaluate the impact of AT on circulating MMP-9, and if the metabolic syndrome might have a modifying effect.
Methods:
Gene expression of MMP-9 was measured in AT, isolated adipocytes, atherosclerotic plaques, macrophages and various other human tissues using real-time PCR. Relationships between plasma MMP-9 (ELISA), adiposity, and metabolic syndrome were analyzed in a population-based cohort of 61-year-old men (n=513). Both AT mRNA levels and circulating levels of MMP-9 were measured in obese subjects (n=40) with and without the metabolic syndrome, treated with a weight-reducing diet.
Results:
Bone marrow, atherosclerotic plaques and macrophages had considerably higher MMP-9 mRNA than subcutaneous AT and isolated adipocytes. Among the 61-year-old men, active plasma MMP-9 concentrations were associated with several metabolic syndrome factors, and inflammatory markers, but not body mass index (BMI). In obese patients with, but not without metabolic syndrome AT mRNA levels and circulating MMP-9 declined during weight reduction, but there was no association between changes in plasma MMP-9 and BMI.
Conclusion:
The results show that adipose tissue per se is not associated with circulating MMP-9. Components of the metabolic syndrome, such as circulating insulin and glucose were related to plasma MMP-9 both in the observation and dietary weight loss studies.
Insights
Adipose tissue does not significantly impact circulating matrix metalloproteinase 9 (MMP-9) levels. Metabolic syndrome factors, not adiposity, influence MMP-9, suggesting its potential as a biomarker is not compromised by adipose tissue.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Matrix metalloproteinase 9 (MMP-9) is implicated as a biomarker in atherosclerosis and cancer.
- Adipose tissue (AT) production of MMP-9 could potentially confound its use as a biomarker.
- The influence of AT and metabolic syndrome on circulating MMP-9 requires clarification.
Purpose of the Study:
- To investigate the impact of adipose tissue on circulating MMP-9 levels.
- To determine if metabolic syndrome modifies the relationship between AT and MMP-9.
- To assess MMP-9 as a biomarker in the context of metabolic syndrome and obesity.
Main Methods:
- Real-time PCR to quantify MMP-9 gene expression in various human tissues, including AT and isolated adipocytes.
- ELISA to measure plasma MMP-9 concentrations in a cohort of 61-year-old men (n=513).
- Analysis of associations between plasma MMP-9, adiposity, and metabolic syndrome, including obese subjects undergoing dietary weight reduction.
Main Results:
- MMP-9 mRNA levels were significantly higher in bone marrow, atherosclerotic plaques, and macrophages compared to subcutaneous AT.
- Plasma MMP-9 concentrations in older men correlated with metabolic syndrome factors and inflammatory markers, but not BMI.
- In obese patients with metabolic syndrome, AT MMP-9 mRNA and circulating MMP-9 decreased with weight loss, independent of BMI changes.
Conclusions:
- Adipose tissue itself is not directly associated with circulating MMP-9 levels.
- Circulating insulin and glucose, key components of metabolic syndrome, are linked to plasma MMP-9.
- These findings suggest that MMP-9's utility as a biomarker is not diminished by adipose tissue, but is influenced by metabolic state.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Extracellular Matrix

